10-K: Simply Good Foods Reports Mixed FY25 Results Amid Atkins Impairment

Simply Good Foods reported a 9% increase in net sales for fiscal year 2025, driven by Quest and OWYN, but saw net income decline due to a significant impairment charge on its Atkins brand and higher operating expenses.

Summary

• Net sales increased by 9.0% to $1,450.9 million for the fifty-two weeks ended August 30, 2025, compared to $1,331.3 million in the prior fiscal year.
• Gross profit rose by 2.8% to $525.7 million, but gross profit margin decreased by 220 basis points to 36.2% due to unfavorable commodity expenses and lower margins from the OWYN business.
• Net income decreased by $35.7 million to $103.6 million for fiscal year 2025, down from $139.3 million in the previous year.
• Operating expenses increased by 20.9% to $368.9 million, primarily due to a $60.9 million loss on impairment related to the Atkins brand and licensing agreements, and $20.3 million in OWYN integration expenses.
• Adjusted EBITDA increased by 3.4% to $278.2 million.
• Basic earnings per share (EPS) was $1.03, a decrease from $1.39 in the prior year, and diluted EPS was $1.02, down from $1.38.
• The Atkins brand experienced continued declines in net sales, primarily due to a reduction in retail distribution, including at Walmart Inc.
• The OWYN Acquisition, completed in June 2024 for approximately $281.9 million, contributed to volume growth for the OWYN brand.
• The company repurchased 1,592,471 shares of common stock for $50.9 million during fiscal year 2025, with $20.7 million remaining under the existing program as of August 30, 2025.
• The Board of Directors approved a $150.0 million increase to the stock repurchase program on October 21, 2025.

Sentiment

Score: 4

Explanation: While net sales grew, driven by Quest and the OWYN acquisition, the significant impairment charge on the Atkins brand, coupled with a decline in gross profit margin, net income, and EPS, indicates notable challenges. The increase in Adjusted EBITDA is positive, but the overall profitability picture for the period is weaker, reflecting integration costs and brand struggles. The increased share repurchase program is a positive signal for shareholder value, but the underlying operational issues, particularly with Atkins, temper overall sentiment.

Positives

• Net sales increased by 9.0% to $1,450.9 million, demonstrating overall revenue growth.
• Quest and OWYN brands showed strong volume growth, offsetting declines in Atkins.
• Adjusted EBITDA increased by 3.4% to $278.2 million, indicating improved operational performance before certain non-cash and non-recurring items.
• The company's Board of Directors approved a $150.0 million increase to the stock repurchase program, signaling confidence in future shareholder value.
• Interest expense decreased by $2.8 million due to principal payments on the Term Facility.

Negatives

• Net income decreased by $35.7 million to $103.6 million, a significant decline from the prior year.
• Gross profit margin decreased by 220 basis points to 36.2%, primarily due to unfavorable commodity expenses and lower margins from the OWYN business.
• A $60.9 million loss on impairment was recognized for the Atkins brand and trademarks indefinite-lived intangible asset and licensing agreements finite-lived intangible asset.
• The Atkins brand experienced continued declines in net sales due to reduced retail distribution, including a reduction in product assortment at Walmart Inc.
• Operating expenses increased significantly by 20.9%, driven by the impairment charge and $20.3 million in integration expenses related to the OWYN Acquisition.
• Basic and diluted earnings per share both decreased compared to the prior fiscal year.

Risks

• Changing consumer preferences, habits, and perceptions of nutritional snacking products may negatively affect brand loyalty and net sales.
• Inability to compete successfully in the highly competitive nutritional snacking industry, especially with increasing focus on macronutrient-focused products and the growing acceptance of weight management medications (GLP-1s).
• Dependence on a global supply chain and the adverse effects of supply chain constraints, inflationary pressures, and tariffs on costs and profitability.
• Inability to maintain or increase product prices to offset rising input costs, potentially leading to reduced sales volumes or profitability.
• Failure to successfully implement growth strategies, including identifying new demographics, developing innovative products, and securing shelf space.
• Damage to brand or organizational reputation from negative media, social media, or third-party reports, regardless of accuracy.
• Vulnerability to economic and other events and trends in North America due to geographic focus.
• Disruptions to business operations, supply chain, and production processes caused by pandemics, epidemics, or disease outbreaks.
• Shortages or interruptions in the supply or delivery of core ingredients, packaging, products, or equipment due to reliance on a limited number of third-party suppliers and contract manufacturers.
• Reliance on sales to a limited number of retailers (Walmart Inc. 31%, Amazon 18%), with at-will contracts that do not guarantee recurring or minimum purchase amounts.
• Losses, disruption, or lack of efficiency in the fulfillment network, primarily managed by a single-sourced third-party logistics provider.
• Negative effects on crop supplies and supply chain infrastructure from severe weather conditions, natural disasters, government regulations related to climate change, and geopolitical events.
• Risks associated with mergers, acquisitions, or joint ventures, including difficulties in integration, failure to realize anticipated benefits, and diversion of management's attention (e.g., OWYN Acquisition).
• Inadequate protection of intellectual property and other proprietary rights.
• Inadequacy, failure, or interruption of information technology systems, and exposure to online security risks, including security breaches and identity theft.
• Non-compliance with federal, state, and local regulations (e.g., FDA, FTC) regarding product manufacturing, food safety, labeling, and advertising.
• Litigation or legal proceedings, including class action lawsuits, which could expose the company to significant liabilities and harm its reputation.
• Adverse effects on financial condition and ability to operate due to indebtedness and changes in interest rates.
• Need for additional capital in the future, which may not be available on acceptable terms or at all.
• Significant costs and management time required for operating as a public company, including compliance with new regulations (e.g., climate-related disclosures).
• Potential for future impairment charges on noncurrent assets, including trademarks, goodwill, and other intangible assets.
• Limitations on the ability to pay dividends or satisfy financial obligations due to the company's structure as a holding company.
• Stock price volatility due to various factors, including market conditions and company-specific announcements.
• Anti-takeover provisions in corporate documents and Delaware law that could impair takeover attempts.
• Regulatory, economic, political, and social risks associated with international operations, including fluctuations in exchange rates and changes in trade agreements.
• Exclusion of certain Board members from the doctrine of corporate opportunity, potentially leading to competition with directors or their affiliates.

Future Outlook

The company expects to continue building on existing capabilities, strengthening brand positions, and investing in business and operating efficiencies. Management is evaluating strategies to offset cost increases through pricing actions and cost savings efforts for fiscal year 2026. The company intends to expand its wellness platform through innovation, organic growth, and acquisition opportunities, particularly in the fragmented nutritional snacking space and complementary adjacent categories.

Management Comments

• Our consolidated results of operations for the fiscal year ended August 30, 2025, were primarily driven by Quest and OWYN volume growth, which more than offset continued declines in Atkins driven primarily by a reduction of distribution.
• The Company's gross margin was affected by the unfavorable effects of higher commodity expenses compared to the prior year and lower gross profit margins of the OWYN business.
• We are continuing to evaluate these factors and our ability to potentially offset all or a portion of cost increases through pricing actions and cost savings efforts for fiscal year 2026.
• We are looking to communicate to consumers who have elected to use these medications what we believe are the complementary benefits of using our products to support achieving or maintaining their weight management goals.

Industry Context

The nutritional snacking industry is highly competitive and fragmented, driven by consumer mega-trends such as increased protein consumption, low-carb/low-sugar diets, plant-based options, and a greater focus on health and wellness. The industry is also influenced by the growing popularity of clinical solutions for weight management, such as GLP-1 medications, which the company aims to complement with its products. Volatile ingredient costs and supply chain constraints continue to be significant industry-wide challenges.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results for a detailed assessment against global benchmarks. It generally notes that the nutritional snacking industry is fragmented and highly competitive, with numerous multinational, regional, and local companies, some with greater financial resources and market presence.

Legal Proceedings

• Not presently a party to any litigation believed to be material, and unaware of any pending or threatened litigation that could have a material adverse effect on business, operating results, financial condition, or cash flows.

Stakeholder Impact

• Shareholders: Experienced a decrease in net income and EPS, but the company's commitment to shareholder value is reinforced by an increased stock repurchase program.
• Consumers: Will see continued product innovation, expanded distribution, and targeted marketing efforts, including messaging around complementary benefits with weight management medications.
• Employees: Benefit from training and development, inclusion & belonging initiatives, and competitive total rewards packages, including paid parental leave and flexible workdays.
• Retailers: Will experience shifts in product offerings, with a focus on replacing lower-performing Atkins products with Quest and OWYN, and continued reliance on a limited number of key retailers.
• Suppliers/Contract Manufacturers: Face ongoing challenges with supply chain constraints and inflationary pressures, requiring the company to actively manage costs and relationships.

Next Steps

• Bolster the highest performing Atkins products and work with retailers to replace lower performing Atkins products with higher performing Quest and OWYN products.
• Continue to enhance, strengthen, and expand product offerings with new and innovative flavors, forms, and packaging alternatives.
• Pursue disciplined merger and acquisition transactions to expand the nutritional snacking platform and enter complementary adjacent snacking categories.
• Expand distribution in 'white space' opportunities across mass retail, grocery, convenience, club stores, and e-commerce channels.
• Continue marketing efforts to increase household penetration and attract new consumers beyond core historic buyers, including those using weight management medications.
• Monitor developments and evaluate the impact of new accounting pronouncements, such as the Pillar Two Model Rules and the H.R.1 Tax Act, on future financial statements.

Key Dates

Recommendation

Simply Good Foods demonstrated revenue growth driven by its Quest and OWYN brands, and an increase in Adjusted EBITDA. However, the significant impairment charge on the Atkins brand, coupled with a decline in net income and gross profit margin, signals underlying challenges. While the company is taking strategic actions to address these issues and has increased its share repurchase program, the mixed financial performance and ongoing brand-specific pressures warrant a cautious 'hold' recommendation. Investors should monitor the effectiveness of the company's strategic shifts, particularly the turnaround efforts for Atkins and the successful integration of OWYN, before considering further investment.

Keywords

Nutritional Snacking, Protein Bars, RTD Shakes, Quest, Atkins, OWYN, SEC Filing, Financial Results, Consumer Packaged Goods, Acquisition, Impairment, Supply Chain, Inflation, Stock Repurchase, Corporate Governance, Risk Management